Sarah Anderson, oncology strategy lead director, Novotech, discusses the growing prominence of triple-negative breast cancer clinical trials in the Asia-Pacific region, and the significant investments ...

When you think of clinical trials for cancer, testing a new medication may come to mind. But drugs aren’t the only thing these trials investigate. There’s a growing world of nonpharmaceutical clinical ...

An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of. For patients with triple-negative breast cancer, there are now several clinical ...

SYDNEY--(BUSINESS WIRE)--Novotech, the leading global full-service clinical Contract Research Organization (CRO), has released a comprehensive report analyzing the global clinical trial and drug ...

From advancing cancer care for future generations to being monitored more closely for disease progression, there are plenty of reasons to consider joining a cancer clinical trial. If your current ...

Many people think of clinical trials as a last-ditch effort for cancer patients. In 2025, amid a flurry of new treatments enabling people diagnosed with cancer to live longer and better, ...

Clinical trials are vital for developing safer, more effective metastatic breast cancer treatments, yet participation is low due to access and financial barriers. Trials progress through phases, from ...

Editor’s note: This round‑up is based on press releases, peer‑reviewed publications, and company communications received in January and February 2026. All results are preliminary unless stated, and ...

I am a cancer researcher and a cancer survivor. A few nights ago, I came across a post on X by @NIH that (seemingly) proudly announced massive cuts to the indirect cost rate on all current and future ...

In clinical trials, Russia’s novel cancer vaccine, Enteromix, has demonstrated 100% efficacy and safety, a breakthrough that could revolutionize cancer therapy. This discovery is being heralded as ...

We extracted 20,894 trials from Cancer.gov from the application programming interface (API) of the NCI CTRP. We quantified biomarker rates in cancer subtypes, described the geographic distribution of ...